Shmuel A. Ben-Sasson

Corporate Officer/Principal at The Hebrew University of Jerusalem

Health Technology

Consumer Services

Profile

Shmuel A.
Ben-Sasson is the founder of Chiasma, Inc. (founded in 2001) and Raziel Therapeutics RT Ltd.
(founded in 2012).
Dr. Ben-Sasson is also the founder of Keryx Biopharmaceuticals, Inc. Currently, Dr. Ben-Sasson holds the position of Associate Professor-Experimental Medicine at The Hebrew University of Jerusalem.

Shmuel A. Ben-Sasson active positions

Companies	Position	Start
The Hebrew University of Jerusalem	Corporate Officer/Principal	-

All active positions of Shmuel A. Ben-Sasson

Former positions of Shmuel A. Ben-Sasson

Companies	Position	End
CHIASMA, INC.	Founder	-
Raziel Therapeutics RT Ltd. Raziel Therapeutics RT Ltd. Pharmaceuticals: MajorHealth Technology Raziel Therapeutics RT Ltd. develops innovative technology to treat obesity disease. It is developing RZL-12, is a potential first-in-class, injectable drug for the reduction of fat cell mass. the firm developed a novel drug (NCE) that after a single injection into subcutaneous fat, converts white adipose tissue (WAT) into brown adipose tissue-like. The company was founded by Shmuel A. Ben-Sasson in 2012 and is headquartered in Jerusalem, Israel.	Founder	-
KERYX BIOPHARMACEUTICALS	Corporate Officer/Principal	-

See the detail of Shmuel A. Ben-Sasson's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Shmuel A. Ben-Sasson's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
Keryx Biopharmaceuticals, Inc. Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Keryx Biopharmaceuticals, Inc. engaged in the manufacture, development, and commercialization of medicines for use in treating human diseases. The company was founded in August 1, 2002 and was headquartered in Cambridge, MA.	Health Technology
Chiasma, Inc. Chiasma, Inc. Pharmaceuticals: MajorHealth Technology Chiasma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of oral forms of therapies that are available by injection. Its products include octreotide capsules. The company was founded by Shmuel A. Ben-Sasson and Guy Yachin in 2001 and is headquartered in Needham, MA.	Health Technology
Raziel Therapeutics RT Ltd. Raziel Therapeutics RT Ltd. Pharmaceuticals: MajorHealth Technology Raziel Therapeutics RT Ltd. develops innovative technology to treat obesity disease. It is developing RZL-12, is a potential first-in-class, injectable drug for the reduction of fat cell mass. the firm developed a novel drug (NCE) that after a single injection into subcutaneous fat, converts white adipose tissue (WAT) into brown adipose tissue-like. The company was founded by Shmuel A. Ben-Sasson in 2012 and is headquartered in Jerusalem, Israel.	Health Technology

See company connections